Position
Chief Executive Officer
Company
Atopia Therapeutics
GenevaBiotechnologyHealth CareTherapeuticsDescription
Atopia Therapeutics, formerly known as HpVac, has appointed Dr. Grégoire Chevalier as the new chief executive officer (CEO). The company has repositioned itself to better reflect its commitment to addressing the growing global burden of atopic diseases.
Quick answer
Atopia Therapeutics Appoints Dr. Grégoire Chevalier as Chief Executive Officer (May 7, 2024). Atopia Therapeutics is based in Geneva, Geneva, Switzerland.
- Who is the new Chief Executive Officer at Atopia Therapeutics?
- Atopia Therapeutics named Grégoire Chevalier Chief Executive Officer, announced May 7, 2024.
- What did Atopia Therapeutics announce on May 7, 2024?
- Atopia Therapeutics, formerly known as HpVac, has appointed Dr. Grégoire Chevalier as the new chief executive officer (CEO). The company has repositioned itself to better reflect its commitment to addressing the growing global burden of atopic diseases.
- What does Atopia Therapeutics do?
- Atopia Therapeutics is focused on the development of a preventive and therapeutic first-line therapy against asthma, eczema, food allergies and related allergic diseases.
- Where is Atopia Therapeutics based?
- Atopia Therapeutics is based in Geneva, Geneva, Switzerland.
- Which similar companies made leadership changes around the same time?
- ALX Oncology (May 7, 2024), Cellarity (May 7, 2024), neurocare (May 7, 2024) and YS Biopharma (May 7, 2024) also announced leadership changes within 45 days of Atopia Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- ALX Oncology Appoints Allison Dillon, Ph.D., as Chief Business Officer (May 7, 2024)
- Cellarity Appoints Christopher Woelk, Ph.D. as Vice President and Head of Platform (May 7, 2024)
- neurocare Appoints Tariq El-Titi as Senior Vice President for Middle East and North-Africa Region (May 7, 2024)
- YS Biopharma Appoints Dave Chenn as Interim CEO and Hui Shao as Co-CEO and CBO (May 7, 2024)
- AdvanCell Appoints Chris Horvath as Chief Commercial and Operating Officer and Gary Li as Chief Strategy Officer (May 8, 2024)
- Ratio Therapeutics Inc. Appoints Marc Becker as Chief Financial Officer and Chief Operating Officer (May 6, 2024)
Who to call at Atopia Therapeutics, and when
A new leader at Atopia Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Atopia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Atopia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Atopia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Atopia Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Atopia Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.